ended 30 September 2020 are as follows: change Q3/2020 Q3/2019 increase (decrease) Sales 277.7 172.6 60.9% Other income 2.5 4.1 -39.9% Cost of sales - 207.6 - 159.6 -30.1% Selling expenses - 7.9 - 4.5
change Revenue from Non-Social Security 251.34 248.35 1% Revenue from Social Security 195.89 197.53 -1% Revenue from Hospital Operations 447.23 445.88 0% Cost of Hospital Operations 304.70 285.42 7% Gross
PERFORMANCE Consolidated Financial Statements Change Change Q2 2019 Q1 2020 Q2 2020 YoY QoQ 1H 2019 1H 2020 YoY THB mm THB mm THB mm % % THB mm THB mm % Total Revenue and Share of Profit 3,074.1 1,277.8 1,966.7
. Challenges persisted, including uneven income recovery, restrained spending in mid to low-income segments, high household debt, and global macroeconomic uncertainties. As a consequence, the overall economic
compared to the same period last year. Table 1: Sales Revenue by Product Line for the Three Months Period Ended 31 December (YoY) Product Line/ Business Group Consolidated financial statements Change
expect the improvement after the pandemic of COVID-19 ends. Table 1 : Sales Revenue by Product Line for the Three Months ended 31 March (3M YoY) Sales by geography Consolidated financial statements Change
3.15 26% Core EBITDA/t (US$/t)) 111 122 90 23% 110 89 24% Net Operating Debt to Equity 0.54 0.57 0.88 (39)% 0.54 0.88 (39)% Note: (1) Consolidated financials are based upon elimination of intra-company
Analysis (MD&A) 3 Q2/2020 Operating Results Overall operating results of the Company and its subsidiaries (unit: THB million) Q2/19 Q1/20 Q2/20 change +/(-) 6M/19 6M/20 Change +/(-) YoYYoY QoQ Operating
of June 30th, 2024, which can be summarized as follows: 1) Profit & Loss Analysis : Q2 2024 (3 Months) (Unit : Million Baht unless otherwise stated) Q2 2024 Q2 2023 Change Amount % Change Total